Aclaris Therapeutics secures global rights to Biosion’s antibodies
Aclaris Therapeutics has secured an exclusive licence from Biosion for the global rights to two new antibodies, BSI-045B and ...
Doctor debunks four common eczema myths which are untrue
Therefore, even individuals without childhood eczema may experience it later in life. Dr Grant has debunked the common ...
Medscape16h
Dupilumab Beneficial When Antihistamines Fall Short for Chronic Spontaneous Urticaria
Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
'I'm a doctor - these four common eczema myths are completely untrue'
There are lots of misconceptions around eczema, from poor hygiene to the skin condition disappearing on its own - there is a ...
Business Insider18h
Eli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss
“Lilly Canada stands behind Ebglyss as a first-line biological therapy for the treatment of atopic dermatitis and we remain committed ... Try Now>> See today’s best-performing stocks on TipRanks >> ...